United States

Back to map

Showing 341-350 of 353 grants

Title Institution Researcher Program Duration Total Award Amount
In vivo validation and translational development of minimally immunogenic beta cells Arizona Board of Regents, University of Arizona Deepta Bhattacharya Cures 01-May-2026 to 30-April-2028 $698,423.87
Towards non-invasive imaging and improvement of islet engraftment via vascularization and oxygenation Arizona Board of Regents, University of Arizona Klearchos Papas Cures 01-October-2025 to 30-September-2027 $897,151.29
Oxygen Enabled High-capacity Vascularized Devices for ß-cell Replacement Therapy in Humans Arizona Board of Regents, University of Arizona Klearchos Papas Cures 01-September-2023 to 31-May-2027 $2,852,490.70
Deciphering the logic of genetic variant interactions in autoimmunity Arc Insitute Maya Arce Cures 01-September-2026 to 31-August-2027 $148,614.38
Evaluating the Initial Efficacy, Acceptability, and Feasibility of BFST-DT, an Intervention for Improving Transition Readiness for Adolescents and Emerging Adults with Type 1 Diabetes Ann & Robert H. Lurie Children’s Hospital of Chicago Jaclyn Papadakis Improving Lives 01-May-2023 to 30-April-2027 $396,471.68
A hybrid effectiveness implementation trial of an intervention to reduce diabetes-specific emotional distress. Ann & Robert H. Lurie Children’s Hospital of Chicago Jill Weissberg-Benchell Improving Lives 01-September-2024 to 31-August-2029 $567,017.00
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression in Young Adults with Type 1 Diabetes Albert Einstein College of Medicine Jeffrey Gonzalez Improving Lives 01-December-2022 to 30-November-2026 $1,672,180.00
Telemedicine-Delivered Cognitive Behavioral Therapy to Reduce Diabetes Distress in Young Adults with Type 1 Diabetes (CBT-DD) Albert Einstein College of Medicine Jeffrey Gonzalez Improving Lives 01-September-2021 to 30-June-2027 $1,870,600.00
Localized Immunosuppressive Antibody Therapy for Enhancing Islet Graft Survival in Type 1 Diabetes Aeterna Therapeutics Maria Kondratyev Cures 01-May-2026 to 28-February-2027 $200,000.00
Repurposing Cardiorenal Drugs for T1D: Building Evidence from Existing Trials (ReCaRD T1D) AdventHealth Richard Pratley Improving Lives 01-September-2023 to 20-November-2026 $110,840.00